Floatz logo

Oxycodone

Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer CenterSmall moleculePhase 3Active
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
73/ 100

Competitive context

64 Active assets in the Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
National Cancer Institute (NCI)
Phase 3BBB
Fludarabine
Memorial Sloan Kettering Cancer Center
Phase 4BBB
Monomethyl Fumarate
Memorial Sloan Kettering Cancer Center
Phase 3BB
Eloxatin
National Cancer Institute (NCI)
Phase 4BB
CYCLOSPORIN A
City of Hope Medical Center
Phase 3BB

View all 50 →

Same molecule, other indications

Oxycodone is also rated in:

Low Back PainDormant
BBB
Indicative ·
77 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
osteoarthritisDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →